Neurological Institute Outcomes
Headache
Chronic Migraine
Chronic migraine refers to migraine headaches occurring at least 15 days per month, frequently associated with significant functional impairment and depression.
Outcomes of Treatment in Chronic Migraine Patients (N = 73)
2023
GAD-7 = Generalized Anxiety Disorder Questionnaire, HIT-6 = Headache Impact Test, PHQ-9 = Patient Health Questionnaire, PROMIS = Patient Reported Outcome Measurement Information System.
In 2023, 73 patients with chronic migraine completed at least 1 questionnaire following treatment. Of the 15 patients who reported HIT-6 scores > 50 at initial evaluation (higher scores indicate greater impairment secondary to headache pain¹), 46.7% reported improvement. The PROMIS is a self-reported measure of physical and emotional health status reflecting health-related quality of life.² Of the 38 patients who reported initial PROMIS global health more than one-half standard deviation below the normative mean, 78% improved or remained stable. Of the 35 patients who reported initial depressive symptoms above the cutoff of ≥ 10 points for the PHQ-9 (higher scores indicate greater depression³), 25.7% remained improved at six months follow-up. Of the 28 patients who reported initial anxiety symptoms above the cutoff of ≥ 10 points for the GAD-7,⁴ 17.9% reported improvement at follow-up.